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Abstract
Induced pluripotent stem (iPS) cells are generated from adult somatic cells by transduction of defined factors. Given their
unlimited proliferation and differentiation potential, iPS cells represent promising sources for cell therapy and tools for
research and drug discovery. However, systems for the directional differentiation of iPS cells toward paraxial mesodermal
lineages have not been reported. In the present study, we established a protocol for the differentiation of mouse iPS cells
into paraxial mesodermal lineages in serum-free culture. The protocol was dependent on Activin signaling in addition to
BMP and Wnt signaling which were previously shown to be effective for mouse ES cell differentiation. Independently of the
cell origin, the number of transgenes, or the type of vectors used to generate iPS cells, the use of serum-free monolayer
culture stimulated with a combination of BMP4, Activin A, and LiCl enabled preferential promotion of mouse iPS cells to a
PDGFR-a+/Flk-12 population, which represents a paraxial mesodermal lineage. The mouse iPS cell-derived paraxial
mesodermal cells exhibited differentiation potential into osteogenic, chondrogenic, and myogenic cells both in vitro and
in vivo and contributed to muscle regeneration. Moreover, purification of the PDGFR-a+/KDR2 population after
differentiation allowed enrichment of human iPS cell populations with paraxial mesodermal characteristics. The resultant
PDGFR-a+/KDR2 population derived from human iPS cells specifically exhibited osteogenic, chondrogenic, and myogenic
differentiation potential in vitro, implying generation of paraxial mesodermal progenitors similar to mouse iPS cell-derived
progenitors. These findings highlight the potential of protocols based on the serum-free, stepwise induction and
purification of paraxial mesodermal cell lineages for use in stem cell therapies to treat diseased bone, cartilage, and muscle.
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Introduction
Embryonic stem (ES) cells have been investigated both as an
experimental tool for developmental biology and as a source of
cell-based therapies due to their potential for self-renewal and
differentiation into all cell lineages. Novel ES cell-like pluripotent
stem cells, termed induced pluripotent stem (iPS) cells, have been
generated from mouse [1] and human [2,3] somatic cells by the
introduction of 4 transcription factors. These iPS cells have
opened the gateway for cell transplantation-based regenerative
medicine by overcoming the ethical argument against human ES
cells [4]. The original technology to generate iPS cells depended
on the stable integration of 4 transgenes. However, the use of non-
integrative vectors for gene transfer [5] or replacement of the c-
Myc oncogene with other safer genes such as L-Myc [6] or Glis-1
[7] permits generation of iPS cells that lack transgenes or
oncogenes. Such technical advancements reduce the risk of
tumorigenesis that results from reactivation of c-Myc transgenes.
However, there is still a risk of teratoma formation, derived from
residual undifferentiated cell populations after transplantation of
differentiated iPS cells. Thus, efficient differentiation of iPS cells
into the progenitor cells of interest and their maximal purification
is required before transplantation. Moreover, suitable differenti-
ation markers should be used to determine the signaling
mechanisms that govern pluripotent stem cell differentiation
toward specific lineages, so that recombinant proteins and small
molecules can be used to direct differentiation.
Previously, we employed a murine ES cell in vitro differentiation
culture system to show that expression of platelet-derived growth
factor receptor a (PDGFR-a) allows efficient identification of
paraxial mesodermal progenitors in combination with negative
selection of Flk-1 expression–a lateral mesodermal marker [8].
The expression of PDGFR-a was detected in the paraxial
mesoderm and somites as well as in neural tube and future spinal
cord during mouse embryogenesis [9,10]. Analysis of the in vitro
fate of ES cell-derived PDGFR-a+/Flk-12 cells demonstrated their
potential to differentiate into osteocytes, chondrocytes, and skeletal
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muscle cells, which are derivatives of somites [8,11]. We also
showed that mouse ES cells can be directed toward the paraxial
mesodermal lineage by a combination of bone morphogenetic
protein (BMP) [12] and Wnt [13] signaling under chemically-
defined conditions [14]. However, it is not known whether iPS
cells also have the potential to give rise to paraxial mesodermal
lineages by stimulating BMP and Wnt signaling cascades.
In the present study, we show that BMP4 and LiCl, which
activate Wnt signaling, promote differentiation of both mouse iPS
and ES cells to paraxial mesodermal lineages under serum-free
conditions. However, unlike mouse ES cells, the self-renewal and
differentiation of mouse iPS cells to paraxial mesodermal lineages
is highly dependent on Activin A [15], which prevents apoptosis of
mouse iPS cells in serum-free condition. In this serum-free
differentiation system, mouse iPS cells efficiently differentiate into
PDGFR-a+/Flk-12 paraxial mesodermal progenitors and, to a
lesser extent, into PDGFR-a+/Flk-1+ immature and PDGFR-
a2/Flk-1+ lateral mesodermal progenitors. The iPS cell-derived
paraxial mesodermal progenitors exhibit osteogenic, chondrogen-
ic, and myogenic differentiation potential both in vitro and in vivo.
Moreover, sorting of PDGFR-a-positive and KDR [16] (a human
homolog of mouse Flk-1)-negative populations also allows
enrichment of paraxial mesodermal progenitors in induced human
iPS cells which give rise to osteogenic, chondrogenic and myogenic
cells in vitro.
Results
Activin A is an Essential Factor for Paraxial Mesodermal
Differentiation of Mouse iPS Cells
To establish chemically defined conditions for paraxial meso-
dermal differentiation in vitro, iPS cells must be cultured without
feeder cells. Thus, the growth-factor requirement of mouse iPS
cells during paraxial mesodermal differentiation was analyzed by
performing an in vitro differentiation study with various doses of
growth factors in chemically defined culture conditions. First, we
assessed the effect of Activin A–a member of the transforming
growth factor beta super family–during the first 3 days of
differentiation (Fig. 1A). Differentiation of iPS cells without
Activin A resulted in minimal proliferation/survival in the absence
of feeder cells (Fig. 1B). However, the addition of Activin A
dramatically enhanced cell number in a dose-dependent manner
(Fig. 1B). Even low dose addition of Activin A supported efficient
cell proliferation (Fig. 1C). Because we observed large amount of
cell death in this serum-free condition, we assessed apoptosis at 24
hour after induction. Although, the serum-free condition caused
apoptosis in more than 80% of iPS cells, addition of Activin A
prevented apoptosis considerably (Fig. 1D). Previously, we have
demonstrated that mouse ES cells can differentiate into paraxial
mesoderm only with an addition of BMP4 in serum-free
conditions [14]. Therefore, we compared the response of mouse
iPS cells to Activin A with that of mouse ES cells. Surprisingly,
mouse ES cells showed fewer apoptosis even in the absence of
Acitivin A (Fig. S1A). Mouse ES cells showed higher expression
level of endogenous Nodal [17] transcription than mouse iPS cells
at 24 after induction (Fig. S1B), suggesting that mouse ES cells
could survive in serum-free condition producing Nodal signaling.
On the other hand, expressions of early mesoendodermal or
mesodermal markers, such as Mixl1 [18], Gsc [19], T [20] and
Eomes [21], on day3 were enhanced by administration of Activin A
in both mouse ES cells and mouse iPS cells (Fig. S1C), suggesting
that Activin-Nodal signal directed differentiation toward meso-
dermal cells in both types of pluripotent stem cells.
Subsequently, paraxial mesodermal differentiation was assessed
by the expression of PDGFR-a [8]. The addition of 5 ng/ml
Activin A resulted in an increase in the number of cells expressing
PDGFR-a to over 30%, and higher doses of Activin A increased
the percentage of PDGFR-a+ cells in a dose-dependent manner
(Fig. 1E).
The PDGFR-a+ cells were sorted and the gene expression level
of mesodermal markers in each PDGFR-a+ population was
analyzed by quantitative real-time RT-PCR. In Activin A-
depleted conditions, there were not enough PDGFR-a+ cells to
allow evaluation of mesodermal induction by RT-PCR analysis.
While all samples were PDGFR-a+, the gene expression levels of
paraxial mesodermal markers (Tbx6 [22] and Mesp2 [23]) varied
with the dose of Activin A– expression was high in preparations
treated with the lowest dose of Activin A and low in those treated
with higher doses (Fig. 1F). In contrast, Activin A did not affect the
expression level of late mesodermal markers such as the
dermomyotome marker Pax3 [24] and the myotome marker
Myf5 [25] (Fig. 1F). Thus, the addition of high doses of Activin A
may alter the characteristics of the PDGFR-a+ population in
mouse iPS cells. Since further lower dose of Activin A than 5 ng/
ml did not influence the induction of paraxial mesodermal
differentiation significantly (Fig. S1D), we used 5–20 ng/ml
Activin A in further experiments because of dose-dependent
proliferation/survival rates of iPS cells.
BMP4 Enhances Cell Proliferation and Affects Lineage-
specific Gene Expression during Mouse iPS Cell
Differentiation
We subsequently assessed the effect of BMP4 during the first 3
days of differentiation under chemically defined culture conditions
in the presence of Activin A (Fig. 2A). The addition of BMP4
enhanced cell number in a dose-dependent manner (Fig. 2B).
While the addition of high dose of BMP4 enhanced cell
proliferation (Fig.2C), the absence of BMP4 resulted in large
apoptosis (Fig. 2D). These two functions of BMP4 administration
cooperated to increase cell number in a dose-dependent manner.
However, the generation of the PDGFR-a+ population was
unaffected by BMP4 treatment (Fig. 2E). The expression of
paraxial mesodermal markers (Tbx6 [22] and Mesp2 [23]) was high
when cells were induced with a medium dose (10 ng/ml) of BMP4
(Fig. 2F). In contrast, the addition of a high dose of BMP4 reduced
the expression level of myogenic mesodermal markers, Pax3 [24]
and Myf5 [25] (Fig. 2F). Down-regulation of Myf5 by high-dose
BMP4 administration is consistent with the evidence that BMP4
acts as an inhibitor for expression of myogenic regulatory genes
Myf5 and MyoD in mouse embryogenesis [26].
Wnt Signaling Enhances Paraxial Mesodermal
Differentiation of Mouse iPS Cells
The effects of growth factors involved in somitogenesis during
mouse development were assessed. During the last 3 days of
differentiation in chemically defined culture conditions, mouse iPS
cells were cultured in the presence or absence of LiCl and Sonic
hedgehog (Shh), respectively (Fig. 3A). The suitable dose of LiCl
and Shh were determined by induction level of PDGFR-a+ cells,
respectively (Fig. S2A and S2B). LiCl enhances Wnt signaling by
translocation of b-catenin from cytoplasm to nucleus (Fig. S2C)
followed by inhibiting the activity of GSK3b [27]. The addition of
both LiCl and Shh to the chemically defined medium enhanced
cell number (Fig. 3B). The increase of cell number was mainly due
to effects of Shh in cell proliferation (Fig. S2D), whereas the
addition of LiCl inhibited apoptosis (Fig. S2E). While the addition
Modeling Paraxial Mesoderm Progenitors from iPSC
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of Shh did not influence generation of PDGFR-a+ cells in
differentiation culture, LiCl prominently induced a PDGFR-a+
cell population (Fig. 3C). Moreover, the expression levels of Tbx6
[22] were higher in the presence of LiCl, whereas the expression
levels of Mesp2 [23] and Pax3 [24] remained unchanged under
these conditions (Fig. 3D). The addition of LiCl, but not Shh,
induced the expression of the myogenic mesodermal marker Myf5
[25] (Fig. 3D). Thus, activation of Wnt signaling by LiCl promoted
paraxial mesodermal differentiation of iPS cells, particularly to
skeletal muscle cell lineages.
Given the aforementioned results, we optimized the culture
conditions for paraxial mesodermal differentiation, as described in
the . The resulting differentiation
protocol was applicable to all types of iPS cells examined,
including those derived from adult tail-tip fibroblast (TTF) or
mouse embryonic fibroblast (MEF) cells and those made by
retroviral transgenesis with 3 or 4 factors or plasmid vectors
(Fig. 3E). PDGFR-a+ cells are distinguishable by their piled-up
morphology like somite in the differentiation culture (Fig. S3).
Although PDGFR-a+ cells can be divided into 2 distinct
populations by the co-expression of Flk-1, up to 90% of
PDGFR-a+ cells cultured under these conditions consisted of
PDGFR-a+/Flk-12 paraxial progenitors (Fig. 3F). Thus, this result
suggests that the PDGFR-a+ population on day 6 of differentiation
Figure 1. Effects of Activin A on paraxial mesodermal differentiation of mouse iPS cells. (A) A scheme for paraxial mesodermal
differentiation of mouse iPS cells with different concentrations of Activin A from day 0 (D0) to day 3 (D3). Activin A was administrated from D0 to D3
at a concentration of 0–20 ng/ml. The cultures also contained BMP4 (10 ng/ml), IGF-1 (10 ng/ml), LiCl (5 mM), and Shh (10 ng/ml). The cells were
analyzed on day 6 (D6) in (B), (E), and (F), or on day 1 (D1) in (C) and (D). (B) Total number of mouse iPS cells after differentiation with the protocol
shown in (A) (n = 3). (C) Proliferation of differentiated mouse iPS cells on D1 assessed by BrdU assay (n = 3). (D) Apoptosis of differentiated mouse iPS
cells on D1 assessed by a proportion of Propidium Iodide (PI) positive/AnnexinV positive cell (n = 3). (E) Dose-dependent induction of PDGFR-a by
Activin A in mouse iPS cell differentiation culture. The percentage indicates the proportion of PDGFR-a+ cells (n = 3). (F) Gene expression profiles of
PDGFR-a+ cells in Activin A-induced cultures (n = 3). The expression level of Tbx6 and Mesp2 genes was reduced in a dose-dependent manner.
*p,0.05, **p,0.01 between selected two samples.
doi:10.1371/journal.pone.0047078.g001
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Materials and Methods
includes mainly paraxial mesodermal progenitors rather than
PDGFR-a+/Flk-1+ immature mesodermal progenitors [8].
Mouse iPS Cell-derived Paraxial Mesodermal Progenitor
Cells are able to Differentiate into Myocytes, Osteocytes,
and Chondrocytes in vitro
We investigated the in vitro differentiation potential of mouse iPS
cell-derived PDGFR-a+ cells to paraxial mesoderm descendants,
such as myocytes, osteocytes, and chondrocytes. PDGFR-a+ cells
isolated by FACS Aria displayed up to 98% purity (Fig. 4A). Tbx6
positive, Mesp2 positive paraxial mesodermal cells were mainly
involved in the PDGFR-a+ population, while Oct3/4 [28] positive,
Nanog [29,30] positive undifferentiated cells were mainly contained
within the PDGFR-a2 population (Fig. 4B). In skeletal myogenic
differentiation culture, myogenin-positive, myosin heavy chain
(MHC)-positive mature myocytes were mainly detected in the
PDGFR-a+ population, whereas very few myogenin-positive cells
were derived from PDGFR-a2 cells (Fig. 4C). Moreover,
approximately 16% of the PDGFR-a+ cells could give rise to
myocytes, whereas only 1% of the PDGFR-a2 cells were
myogenin positive (n = 3) (Fig. 4D). PDGFR-a+ cells differentiated
into osteocytes containing an abundant calcium matrix, as
revealed by Alizarin Red-positive staining in the well (Fig. 4E).
On the other hand, the PDGFR-a2 population exhibited limited
Figure 2. Effects of BMP4 on paraxial mesodermal differentiation of mouse iPS cells. (A) A scheme for the paraxial mesodermal
differentiation of mouse iPS cells with different concentrations of BMP4 from D0 to D3. BMP4 was administrated from D0 to D3 at a concentration of
0–20 ng/ml. The cultures also contained Activin A (5 ng/ml), IGF-1 (10 ng/ml), LiCl (5 mM), and Shh (10 ng/ml). The cells were analyzed on D6 in (B),
(E), and (F), or on day 3 (D3), as shown in (C) and (D). (B) Total number of mouse iPS cells after differentiation with the protocol shown in (A) (n = 3).
(C) Proliferation of differentiated mouse iPS cells on D3 assessed by BrdU assay (n = 3). (D) Apoptosis of differentiated mouse iPS cells on D3 assessed
by a proportion of PI positive/AnnexinV positive cell (n = 3). (E) The expression of PDGFR-a in mouse iPS cell differentiation culture. The percentage
indicates the proportion of PDGFR-a+ cells (n = 3), which was not affected by BMP4. (F) Gene expression profiles of PDGFR-a+ cells in BMP4-induced
cultures (n = 3). The expression of Tbx6 and Mesp2 was higher at a concentration of 10 ng/ml BMP4, whereas the expression of Pax3 and Myf5 was
reduced at higher doses of BMP4. *p,0.05, **p,0.01 between selected two samples.
doi:10.1371/journal.pone.0047078.g002
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Figure 3. Effects of LiCl and Shh on paraxial mesodermal differentiation of mouse iPS cells. (A) A scheme for paraxial mesodermal
differentiation of mouse iPS cells using various combinations of LiCl and Shh from D3 to D6. The cells were analyzed on D6 in (B–F). The cultures also
contained Activin A (5 ng/ml), BMP4 (10 ng/ml), and IGF-1 (10 ng/ml). (B) Total number of mouse iPS cells after differentiation with the protocol
shown in (A) (n = 3). Both LiCl and Shh enhanced proliferation of mouse iPS cells. (C) The expression of PDGFR-a in mouse iPS cells after
differentiation. The percentage indicates the proportion of PDGFR-a+ cells (n = 3). LiCl prominently induced generation of PDGFR-a+ cells. (D) Gene
expression profiles of PDGFR-a+ cultured as shown in (A) (n = 3). LiCl treatment enhanced expression of Myf-5. (E) Differentiation of various types of
Modeling Paraxial Mesoderm Progenitors from iPSC
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potential to form calcium-positive osteocytes, as indicated by
reduced Alizarin Red staining (n = 3) (Fig. 4E). Quantification of
total amount of Alizarin Red dyes in a well demonstrated that
osteogenic cells were mainly contained in PDGFR-a+ population
(Fig. 4F). Furthermore, during in vitro chondrogenesis, the
PDGFR-a+ population formed an Alcian Blue-positive chondro-
cytic colony in the center of a high density micromass cell culture
(Fig. 4G). In contrast, the PDGFR-a2 population did not form
Alcian Blue-positive chondrocytes under the same conditions
(n = 3) (Fig. 4G). Quantification of Alcian Blue-positive area in a
well showed that chondrogenic cells were also contained in
PDGFR-a+ population (Fig. 4H). These results indicate that
PDGFR-a+ cells derived from mouse iPS cells had the potential to
differentiate into paraxial mesodermal descendants in vitro,
including skeletal myocytes, osteocytes, and chondrocytes. Thus,
the mouse iPS cell-derived PDGFR-a+ cells displayed paraxial
mesodermal characteristics.
In vivo Differentiation Potential of Mouse iPS Cell-derived
Paraxial Mesodermal Progenitor Cells
To assess the potential of PDGFR-a+ cells to give rise to
paraxial mesodermal descendants in vivo, we transplanted both
PDGFR-a+ and PDGFR-a2 cells (derived from DsRed/iPS cells)
into the tibial anterior (TA) muscle of immunodeficient mice. Four
weeks after transplantation, tumor formation was only observed in
TA muscle engrafted with PDGFR-a2 cells (n = 3) (Fig. 5A). The
tumor was classified as a teratoma, which consisted of all 3 germ
layers (Fig. 5B, right       panel)
that expressed DsRed (Fig. 5C,    right     panel). Thus, these results
suggest that PDGFR-a2 cells contain undifferentiated iPS cells.
Engraftment of PDGFR-a+ cells resuspended in Matrigel caused
ectopic cartilage formation in the TA muscle (n = 2 for 3
engraftments) (Fig. 5B,    left    panel). Ectopic cartilage was covered
with a capsule and did not form part of the teratoma since it did
not contain any other tissues. As shown in Fig. 5C (left panel),
the ectopic cartilage was derived from engrafted cells that
expressed DsRed. Transplantation into TA muscle of PDGFR-
a+ cells resuspended in Matrigel resulted in the fusion of very few
DsRed-positive cells with host myofiber (data not shown), as
injection with Matrigel may have caused limited migration of
engrafted cells. Therefore, we performed transplantation of
fractionated cells in medium. However, no iPS cell-derived cells
were detected following engraftment in medium, even in the case
of the PDGFR-a2 population (data not shown), which may be due
to the fact that FACS-sorted cells have low adhesion potential. In
order to enhance the adhesion potential of the FACS-sorted cells,
PDGFR-a+ and PDGFR-a2 cells were sorted and reseeded onto
thermoresponsive culture dishes pre-coated with type IV collagen.
Cells were harvested 24 h after re-culture by incubation at RT
without enzymatic treatment. PDGFR-a+ and PDGFR-a2 cells
were transplanted into the TA muscle of immunodeficient mice,
and the engrafted tissues were analyzed 4 weeks after transplan-
tation (n= 3). Detection of DsRed-positive myofibers indicated
that the PDGFR-a+ cells had fused with host myofibers (Fig. 5D,
white arrow). On the other hand, the PDGFR-a2 cells had never
fused with myofibers and were observed in an interstitial area of
muscles (Fig. 5D, white arrowhead). DsRed expression was
confirmed by using an HRP-conjugated secondary antibody to
exclude autofluorescence of mouse myofibers (Fig. 5D, black
arrow and black arrowhead).
To assess the contribution of the engrafted PDGFR-a+ cells to
myogenesis, we transplanted the cells into DMD-null mice, which
is a model mouse for Duchenne muscular dystrophy (DMD) [31].
Four weeks after transplantation, DMD-null mice were sacrificed
and dystrophin [32] expression in engrafted muscle was assessed
by immunohistochemical analysis (n = 3). Dystrophin-positive
myofibers were detected in TA muscle engrafted with PDGFR-
a+ cells (Fig. 5E, white arrow), while no dystrophin expression was
observed in the muscle engrafted with PDGFR-a2 cells (Fig. 5E,
a + cells have potential
to differentiate into functional myogenic cells that fuse with host
myofibers and produce dystrophin. The PDGFR-a+ cells also gave
rise to muscle satellite cells, which are adult stem cells of striated
muscle. The expression of SM/C-2.6 (a surface marker for
quiescent satellite cells [33]) and of Pax7 [34] (a specific
transcriptional factor for satellite cells) was detected in some
DsRed-positive engrafted cells (Fig. 5F and 5G). Therefore, to
assess whether these iPS cell-derived satellite cells were functional,
we isolated single cells from engrafted TA muscle by enzymatic
treatment and recultured them under the culture conditions of
primary satellite cells. The iPS cell-derived DsRed-positive cells
were able to differentiate into MHC-positive myofibers within host
myofibers together with host myocyte (Fig. 5H, white arrow).
These results suggest that PDGFR-a+ cells represent paraxial
mesodermal progenitors that have the potential to differentiate
into both cartilage and functional myogenic cells in vivo.
The Combined Use of 2 Markers–PDGFR-a and KDR–
allows Isolation of Paraxial Mesodermal Progenitors from
Human iPS Cell Differentiation Culture
Next, we investigated paraxial mesodermal differentiation in
human iPS cells. Although we attempted to use the same
differentiation protocol as for mouse iPS cells, human iPS cells
were not viable under these conditions. This may be due to the
inability of human pluripotent stem cells to survive as single cells.
Therefore, human iPS cells were dissociated into small clusters and
differentiated in defined medium containing KSR. Gene expres-
sion profile of differentiated human iPS cells was analyzed during
differentiation from day 0 to day 10 (Fig. 6A). The expression of
undifferentiated markers, such as Oct3/4 [28], Nanog [29,30] and
Sox2 [35] gradually diminished along with differentiation (Fig. 6A).
The expressions of early mesodermal marker T and lateral
mesodermal marker KDR were detected after day 2 and gradually
decreased as differentiation proceeded (Fig. 6A). The expression of
PDGFR-a increased along with differentiation while paraxial
mesodermal markers Tbx6 and Mesp2 were transiently activated
at around day 4–6 (Fig.6A). Based on expression pattern of these
genes, we tried to isolate paraxial mesodermal progenitors
monitoring the expression of two mesodermal surface markers–
PDGFR-a and KDR– at day6 differentiation. As a result,
differentiated human iPS cells were separated into 4 fractions:
PDGFR-a+/KDR+ (double positive; DP), PDGFR-a+/KDR2
mouse iPS cell clones into PDGFR-a+ cells in serum-free induction culture. 3F/TTF: iPS cells induced by 3 factors (Oct3/4, Sox2, and Klf4) using
retroviral transduction from tail-tip fibroblasts. 4F/MEF and 4F-Plasmid/MEF: iPS cells induced by 4 factors (Oct3/4, Sox2, Klf4, and c-Myc) from MEFs
using retroviral transduction (4F/MEF), or plasmid transduction (4F-Plasmid/MEF), respectively. The percentage indicates the proportion of PDGFR-a+
cells (n = 3). (F) Expression profiles of 2 mesodermal markers, PDGFR-a and Flk-1, after mouse iPS cell differentiation. Up to 90% of PDGFR-a+ cells
cultured under these conditions were PDGFR-a+/Flk-12 paraxial progenitors. PDGFR-a+/Flk-1+ and PDGFR-a2/Flk-1+ populations were barely induced
under these conditions. *p,0.05, **p,0.01 between selected two samples.
doi:10.1371/journal.pone.0047078.g003
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      and was derived from engrafted cells
right     panel), suggesting that the PDGFR-
Figure 4. Differentiation potential of mouse iPS cell-derived paraxial mesodermal progenitors in vitro. (A) On day 6, differentiated iPS
cells were sorted into PDGFR-a+ and PDGFR-a2 populations. (B) Gene expression profile for mesodermal and undifferentiated markers in PDGFR-a+
and PDGFR-a2 populations. (C) In vitro myogenic differentiation of sorted cells 7 days after differentiation. The differentiation of PDGFR-a+ cells, but
not PDGFR-a2 cells, into mature myocytes is shown as myogenin+ cells with brown nuclear staining (upper panels) or as myosin heavy chain (MHC)-
positive cells with brown cytosolic staining (lower panels). (D) The ratio of myogenin+ cells to the total number of cells that were Giemsa-positive in
each well was counted. Approximately 16% of PDGFR-a+ cells were myogenin+ (n = 3). (E) In vitro osteogenesis of differentiated mouse iPS cells 28
days after osteocytic induction. The PDGFR-a+ population differentiated into osteocytes, producing an Alizarin Red-positive calcium matrix. The
PDGFR-a2 population showed limited osteogenic potential, as indicated by faint calcium deposits (n = 3, each). (F) Quantification of Alizarin Red dyes
in an osteogenic differentiation culture (n = 3). (G) In vitro chondrogenesis of differentiated mouse iPS cells 21 days after chondrocytic induction. The
Modeling Paraxial Mesoderm Progenitors from iPSC
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(PDGFR-a single positive; PSP), PDGFR-a2/KDR+ (KDR single
positive; KSP), and PDGFR-a2/KDR2 (double negative; DN)
(Fig. 6B). As shown in Fig. 6C, the proportion of each fraction was
similar in 2 distinct human iPS cell clones. Approximately one
third of cells expressed PDGFR-a, and the PSP population rose to
around 20% of cells in both iPS cell clones.
Previously, we reported that while the PSP population displayed
paraxial mesodermal characteristics, the DP population displayed
immature mesodermal characteristics during mouse ES cell
differentiation [8]. Therefore, to assess the characteristics of each
cell population, we performed quantitative PCR analysis of
developmental markers (Fig. 6D). The expression levels of
PDGFR-a and KDR were analyzed to confirm the purity of
each FACs-sorted population. In both iPS cell clones, the paraxial
mesodermal markers Tbx6 and Mesp2 were dominantly expressed
in the PSP population. In contrast, the neuronal marker Pax6 was
specifically detected in the DN population, suggesting that neural
lineage cells were negatively selected by the two mesodermal
markers. Taken together, the gene expression profile indicates that
the PSP population isolated after differentiation of human iPS cells
displays paraxial mesodermal characteristics.
The PDGFR-a+/KDR2 Population Differentiated from
Human iPS Cells Exhibits Paraxial Mesodermal
Characteristics with Differentiating Potentials into
Skeletal Myocytes, Osteocytes, and Chondrocytes in vitro
Next, we investigated the in vitro differentiation potential of the
PSP population derived from human iPS cells to paraxial
mesoderm descendants, such as myocytes, osteocytes, and
chondrocytes. Differentiated human iPS cells at Day6 were
separated into 4 fractions–DP, DN, PSP and KSP– by FACS
Aria and re-cultured for further differentiation. In osteogenic
differentiation culture, Alizarin Red-positive calcium matrix was
dominantly detected in the culture of PSP population, indicating
that PSP cells have enough potential to differentiate into osteocytes
(n = 3) (Fig. 7A). Quantification of total amount of Alizarin Red
dyes in a well demonstrated that osteogenic cells were mainly
contained within PSP population (Fig. 7B). In chondrogenic
differentiation culture, both PSP population and DP population
gave rise to Alcian Blue-positive chondrocytes (n = 3) (Fig. 7C).
Quantification of Alcian Blue-positive area in a well showed that
chondrogenic progenitors were mainly contained in PSP popula-
tion (Fig. 7D). In myogenic differentiation culture, MHC-positive
mature myocytes were selectively detected in the PSP population
(n = 3) (Fig. 7E and 7F). These results indicate that PSP cells
derived from human iPS cells have the potential to differentiate
into three paraxial mesodermal descendants in vitro, including
skeletal myocytes, osteocytes, and chondrocytes. Thus, these
results suggest that the human iPS cell-derived PSP cells represent
paraxial mesodermal progenitors.
Discussion
Since Yamanaka and Takahashi first reported the generation of
pluripotent ES cell-like cells–induced pluripotent stem (iPS) cells–
from mouse fibroblasts by unique gene transfer-based nuclear
reprogramming technology, many researchers have compared the
similarities and differences between ES and iPS cells with respect
to their pluripotency, undifferentiated states, genetic or epigenetic
regulations, and differentiation potentials. For lateral mesodermal
differentiation into cardiomyocytes, endothelial cells, and hema-
topoietic cells, mouse iPS cells have almost identical differentiation
potential to mouse ES cells. In the present study, we demonstrated
a potential of mouse ES and iPS cells for paraxial mesodermal
differentiation, with the exception of the requirement of Activin A
during iPS cell differentiation under serum-free conditions.
Previously, we demonstrated that BMP4 treatment was
sufficient to promote commitment of mouse ES cells to the early
primitive streak-type mesodermal lineage [14] and further their
differentiation to paraxial mesodermal cell types. These findings
are consistent with a previous finding, which showed that Wnt and
Activin/Nodal are essential for the establishment of primitive
streak-type mesodermal precursors during mouse ES cell differ-
entiation and that BMP4 induces the endogenous activation of
Nodal and Wnt pathways [36]. However, in the present study, we
found that mouse iPS cells did not proliferate in the presence of
BMP4 alone and that their survival and paraxial mesodermal
differentiation required Activin A under serum-free conditions.
The iPS cell clones used in this study display near complete
reprogramming and show germline transmission in a chimeric
assay [37], suggesting that the difference in the growth factor
requirement between ES and iPS cells is not due to incomplete
reprogramming of iPS cells. We rather consider that the
requirement of Activin A by iPS cells is due to their intrinsic
characteristics. More than 80% of the mouse iPS cells died by
apoptosis in 24 hours after serum-free differentiation without
Activin A, whereas only 10% of mouse ES showed apoptosis in the
same culture condition. Mouse ES cells activate endogenous
Nodal/Activin signaling in an autocrine fashion to proliferate
under serum-free conditions [38]. Based on the finding that mouse
iPS cells express less transcripts of the Nodal gene than mouse ES
cells, we examined effects of Activin A on the serum-free culture of
mouse iPS cells. As a result, we attained prominently enhanced
survival and proliferation of mouse iPS cells in the presence of
Activin A. On the other hand, the response to Activin A in early
period of differentiation was quite identical between mouse ES and
iPS cells in terms of increased expression of mesoendodermal
genes [39]. Thus, mouse iPS cells are likely less capable of
activating Nodal/Activin signaling, which is essential for their
survival rather than for differentiation. Severe conditions, such as
serum-free monolayer culture, should uncover differences between
ES and iPS cells efficiently.
Although BMP4 was not essential for the induction of paraxial
mesodermal progenitors from mouse iPS cells in the presence of
both Activin A and LiCl and did not influence the proportion of
PDGFR-a+ cells generated in cell culture, the addition of BMP4
affected the composition of PDGFR-a+ cells in a concentration-
dependent manner. In particular, 10 ng/ml of BMP4 enhanced
expression of paraxial mesodermal markers, whereas higher doses
of BMP4 inhibited the expression of the myogenic markerMyf5, as
consistent with previous reports [26]. In contrast, the addition of
LiCl, which activates Wnt signaling via inhibition of GSK3b,
dramatically increased the proportion of PDGFR-a+ cells in
serum-free culture. Mesodermal gene expression patterns in the
presence or absence of LiCl were almost identical, with the
exception of elevated Myf5 expression in the presence of LiCl.
Therefore, these results suggest that Wnt signaling promotes
PDGFR-a+ population gave rise to Alcian Blue-positive chondrocytes. (n = 3, each) (H) Quantification of Alcian Blue positive area in a chondrogenic
differemtiation culture (n = 3). The bars in (C) and (G) represent 100 mm, the bar in (E upper) represents 2 mm and the bar in (E lower) represents
200 mm. **p,0.01 between selected two samples.
doi:10.1371/journal.pone.0047078.g004
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Figure 5. Differentiation potential of mouse iPS cell-derived paraxial mesodermal progenitors toward chondrocytes and myocytes
in vivo. (A) Differentiated iPS cells were sorted into PDGFR-a+ and PDGFR-a2 populations on day 6. The resulting sorted cells were intramuscularly
transplanted into the tibia anterior (TA) muscles of nude mice. Tumor formation was detected in muscle engrafted with the PDGFR-a2 population
(n = 4). (B, C) The PDGFR-a+ population differentiated into chondrocytes in vivo. The iPS-DsRed cell-derived PDGFR-a+ or PDGFR-a2 populations
within Matrigel were grafted into TA muscle. The PDGFR-a2 population formed a teratoma (B, right), and the PDGFR-a+ population formed ectopic
cartilage (B, left; arrow). (C) The teratomas and ectopic cartilage were derived from engrafted cells that expressed DsRed. (D) Differentiation potential
of the PDGFR-a+ population toward skeletal muscle in vivo. The iPS-DsRed cell-derived PDGFR-a+ or PDGFR-a2 populations were recultured on
thermoreactive dishes for 24 h and harvested without enzymatic treatment. The harvested cells were directly transplanted into TA muscles of nude
mice (n = 3, each). Immunohistochemical staining with anti-DsRed antibody was performed to detect engrafted cells. Upper panels: DsRed positive
engrafted cells derived from PDGFR-a+ population fused with host myofibers (white arrow), while DsRed positive engrafted cells derived from PDGFR-
a2 population located in interstitial area of host muscle (white arrowhead). Lower panels: DsRed expression was confirmed by HRP-based
immunohistochemistry (black arrow and black arrowhead). (E–G) The PDGFR-a+ population differentiated to form dystrophin-positive muscle fibers
Modeling Paraxial Mesoderm Progenitors from iPSC
PLOS ONE | www.plosone.org 9 October 2012 | Volume 7 | Issue 10 | e47078
in DMD-null mice. The harvested cells were directly transplanted into TA muscles of DMD-null mice (n = 3, each). (E) Immunohistochemical staining
with anti-dystrophin antibody was performed to assess the contribution of engrafted cells to muscle regeneration. Dystrophin expression was
detected at the injected site of PDGFR-a+ population engrafted muscle (white arrow), while no Dystrophin expression was observed in PDGFR-a2
population engrafted muscle. (F, G) To assess differentiation into satellite cells, immunohistochemical staining with SM/C-2.6 (F) and anti-Pax7 (G)
antibodies was performed. DsRed-positive cells were able to differentiate into satellite cells (arrowheads). (H) DsRed-positive satellite cells
differentiated into mature myocytes in vitro (arrow). The bars in (B), (C), (D), (E), and (H) represent 100 mm. The bars in (F) and (G) represent 10 mm.
doi:10.1371/journal.pone.0047078.g005
Figure 6. Modeling paraxial mesodermal differentiation of human iPS cells. (A) Time course of gene expression profile during
differentiation of human iPS cells. (B) Expression profile of PDGFR-a and KDR in differentiated human iPS cells on day 6. DP, double-positive
population; DN, double-negative population; PSP, PDGFR-a single-positive population; KSP, KDR single-positive population. (C) Proportion of each
fractionated population of differentiated human iPS cells on day 6 (n = 3). About one third of cells were PDGFR-a positive, and around 20% of the
total cells were classified in the PSP population. (C) Gene expression profiles of each population after differentiation of human iPS cells. Tbx6 and
Mesp2 were dominantly expressed in the PSP population. *p,0.05, **p,0.01 PSP versus the other samples (Tbx6 and Mesp2). **p,0.01 DN versus
the other samples (Pax6).
doi:10.1371/journal.pone.0047078.g006
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paraxial mesodermal differentiation, particularly toward myogenic
differentiation, during mouse iPS cell differentiation.
Although some differences in growth factor requirement
between mouse ES cell and iPS cells were observed, the
PDGFR-a+ population derived from mouse iPS cells was almost
identical to that of ES cells with respect to their differentiation
potential toward paraxial mesoderm descendants, such as
osteocytes, chondrocytes, and myocytes. Particularly for myo-
genic differentiation, the iPS cell-derived PDGFR-a+ population
contains myogenic progenitor cells that can give rise to satellite
cells and contribute to regeneration of impaired muscle in DMD-
null mice by the production of dystrophin. However, since the
same PDGFR-a+ population induces ectopic cartilage formation,
even following engraftment into muscle with Matrigel, it will be
necessary to further dissect this population into committed
myogenic and chondrogenic populations by using other markers.
In human iPS cell differentiation, PDGFR-a has been
recognized as a segregation marker for isolating KDR+/
PDGFR-a2 hematopoietic progenitors and KDR+/PDGFR-a+
cardiac progenitors among KDR+ mesodermal progenitors
[40,41]. In the present study, we demonstrated that PDGFR-a
can be effectively used in combination with KDR negative
selection to isolate paraxial mesodermal progenitor cells from
human iPS cells after differentiation as well as in a mouse ES/iPS
cell differentiation system. The human iPS cell-derived PDGFR-
a+/KDR2 cells named PDGFR-a single positive (PSP) population
significantly exhibited higher differentiation potentials to paraxial
mesodermal descendants such as osteocytes, chondrocytes and
myocytes than the other three populations. Whereas the protocols
for osteogenic and chondrogenic differentiation of human iPS cells
were similar to the protocols of mouse iPS cell, myogenic
differentiation had to be customized for human iPS cells. The
human iPS cell-derived PSP population did not differentiate to
myocytes in the presence of serum or KSR, but did differentiate to
myocytes in serum-free condition with additional supplement of
LiCl and a TGF-b signal inhibitor SB-431542 [42]. However,
many other cell types were still observed in this myogenic
differentiation culture and efficiency of myogenesis still remained
low. It will be necessary to explore further purification of
committed myogenic lineage from PSP population by using other
markers.
Finally, the isolation of paraxial mesodermal progenitors during
human iPS cell differentiation will be a first step to purify
osteogenic, chondrogenic and myogenic progenitors by their
segregation from residual undifferentiated stem cells for use in
stem cell therapies to treat diseased bone, cartilage, and muscle.
Figure 7. Differentiation potential of human iPS cell-derived mesodermal populations in vitro. (A) In vitro osteogenesis of differentiated
human iPS cells 28 days after osteocytic induction. On day 6, differentiated human iPS cells were sorted into DP, DN, PSP and KSP populations. The
PSP population differentiated into osteocytes, producing an Alizarin Red-positive calcium matrix. The DP population showed low osteogenic
potential, as indicated by mild calcium deposits (n = 3, each). The DN and KSP populations had very low osteogenic potentials (n = 3, each). (B)
Quantification of Alizarin Red dyes in an osteogenic differentiation culture (n = 3). (C) In vitro chondrogenesis of differentiated mouse iPS cells 21 days
after chondrocytic induction. The PSP and DP populations gave rise to Alcian Blue-positive chondrocytes, while the DN and KSP populations had very
low chondrogenic potentials. (n = 3, each) (D) Quantification of Alcian Blue positive area in a chondrogenic differemtiation culture (n = 3). (E) In vitro
myogenic differentiation of sorted cells 14 days after differentiation. The differentiation of PPS cells, but not the other cells, into mature myocytes is
shown as MHC+ cells with brown cytosolic staining (n = 3, each). (F) The number of MHC+ cells in a myogenic differentiation culture was counted
(n = 3). The bar in (A upper) represents 4 mm, the bar in (A lower), (C) and (E) represents 100 mm. *p,0.05, **p,0.01 PSP versus the other samples.
doi:10.1371/journal.pone.0047078.g007
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Materials and Methods
In vitro Cell Culture and iPS Cell Differentiation
Mouse iPS-MEF-Ng-20D-17 (iPS-Ng), iPS-MEF-Ng-492B-4
(iPS-plasmid), and iPS-TTF-DsRed-256H-18 (iPS-DsRed) iPS
cells were kindly provided by Dr. S. Yamanaka and maintained
as described previously [5,43,44]. Mouse fibroblasts were obtained
from mouse tail-tip or embryo in strict accordance with the
recommendations in the Regulation on Animal Experimentation
at Kyoto University, and the protocol to produce the fibroblasts
was approved by the Animal Research Committee of Kyoto
University. For paraxial mesoderm differentiation, 1.6–2.46105
mouse iPS cells were plated onto a 6-cm dish coated with type IV
collagen (Nitta Gelatin, Inc.) and differentiated in serum-free
culture medium (SF-O3; Sanko Junyaku) supplemented with 0.2%
bovine serum albumin (BSA), 0.1 mM 2-mercaptoethanol (2-ME),
5 ng/ml recombinant human Activin A (Peprotech), 10 ng/ml
recombinant human IGF-1 (Peprotech), and 10 ng/ml recombi-
nant human BMP4 (R&D Systems Inc., Minneapolis). After 3 days
of culture, the medium was replaced with SF-O3 supplemented
with 0.2% BSA, 0.1 mM 2-ME, 5 mM LiCl (Nacalai Tesque), and
10 ng/ml recombinant mouse Shh (R&D). Following 6 days of
culture, paraxial mesodermal progenitor cells were obtained as
PDGFR-a+ cells. For osteocytic and chondrocytic induction,
paraxial mesodermal progenitor cells were sorted as described
below and recultured as previously described [8]. Similarly, for
myogenic differentiation, paraxial mesodermal progenitor cells
were sorted as described below and recultured as described
previously [14].
Human iPS cells (201B7 and 253G4) were also kindly
provided by Dr. S. Yamanaka and maintained as previously
described [2]. Human dermal fibroblasts used for generating
201B7 and 253G4 were purchased from Cell Applications, Inc.
All human iPS cells were established according to procedures
approved by Ethics Committee on Human Stem Cell Research
of the Institute for Frontier Medical Sciences, Kyoto University.
For mesodermal differentiation, feeder cells were depleted by
treatment with 0.25% trypsin (Invitrogen), 0.1 mg/ml collage-
nase IV (Invitrogen), 1 mM CaCl2 (Nacalai Tesque), and 20%
Knockout serum replacement (KSR; Invitrogen) at room
temperature (RT) for 2 min. After feeder cell depletion, human
iPS cells were washed twice with PBS(-), and an appropriate
volume of differentiation medium, [alpha-minimum essential
medium (aMEM; Nacalai Tesque) supplemented with 5% KSR
and 0.1 mM 2-ME] was added to the culture dish. Human iPS
cells were detached by scraping and dissociated into small
clusters by pipetting, which were plated onto dishes coated with
type I collagen (passage ratio, 1:2). Human iPS cells were
cultured in differentiation medium at 37uC with 5% CO2, and
the differentiation medium was changed every 2 days. For
osteocytic and chondrocytic induction, fractionated cells were
sorted as described below and recultured as previously described
[8]. For myogenic induction, the fractionated cells were sorted
as described below and were re-cultured on collagen type I
coated 24-well trays (AGC TECHNO GLASS) in SF-O3 with
5 mM LiCl, 10 ng/mL IGF-1, 10 ng/mL hepatocyte growth
factor (HGF) (R&D systems) and 10 ng/mL basic fibroblast
growth factor (bFGF) (Wako). Three days after re-culture, the
medium was changed again to SF-O3 with 5 mM LiCl, 10 ng/
mL IGF-1 and 5 mM SB-431542 (Stemgent Inc.). Four days
later, the medium was changed again to SF-O3 with 10 ng/mL
IGF-1, 5 mM SB-431542 and 10 ng/mL HGF and the cells
were cultured for seven days.
Antibodies, Cell Staining, FACS Analyses, and Cell Sorting
The rat monoclonal antibody (MAb) APA5 (anti-PDGFR-a) [9]
was kindly provided by Dr. S. Nishikawa. Phycoerythrin-
conjugated streptavidin (BD Pharmingen, San Diego, CA) was
used to detect biotinylated-APA5 antibody. Allophycocyanin
(APC)-conjugated AVAS12 (Anti-Flk-1) MAb was purchased from
Biolegend.
Cultured cells were harvested and collected in 0.05% trypsin-
EDTA (GIBCO, Grand Island, NY). Single-cell suspensions were
stained as previously described [45] and analyzed or sorted with a
FACS Aria (Becton, Dickinson and Company, Franklin Lakes,
NJ).
BrdU Assay
Differentiated iPS cells were labeled with 10 mM BrdU for four
hours at day3 or day6. The BrdU Flow kit (BD Pharmingen) was
used for detection of BrdU positive cells according to the
manufacturer’s protocol.
Apoptosis Assay
Differentiated iPS cells were harvested at day1, day3 or day6.
The Annexin V : FITC Apoptosis Detection Kit I (BD
Pharmingen) was used for detection of apoptotic cells according
to the manufacturer’s protocol.
Transplantation of iPS Cell-derived Mesodermal
Progenitors into Mice
All mouse experiments were carried out according to protocols
approved by the Animal Research Committee of Kyoto Univer-
sity. The PDGFR-a+ and PDGFR-a2 fractions were purified and
collected by FACS Aria. Cells were resuspended in Matrigel
(Invitrogen) or in aMEM supplemented with 10% fetal bovine
serum (FBS; Invitrogen) and 100 mM 2-ME. Alternatively,
collected cells were reseeded onto thermo-responsive culture
dishes pre-coated with type IV collagen and were cultured in
aMEM supplemented with 7% FBS, 10 ng/ml recombinant
human IGF-1 and 100 mM 2-ME. Cells were harvested 24 h after
reseeding by incubation at RT without enzymatic treatment and
were resuspended in the culture media. For intra-muscular
transplantation of immunodeficient mice, the tibia anterior (TA)
muscle of a KSN nude mouse (Japan SLC, Inc., Hamamatsu,
Japan) was treated with Cardiotoxin (CalBiochem) following
diethyl ether anesthesia 24 h before transplantation, which
consisted of the direct injection of 50 ml of cell suspension into
the TA muscle of each mouse. For intra-muscular transplantation
of a Duchenne muscular dystrophy (DMD)-model mouse, a
DMD-null mouse was totally irradiated with 6 Gy of c-rays and
the TA muscle was treated with Cardiotoxin (CalBiochem)
following diethyl ether anesthesia 24 hour before transplantation.
For cell transplantation, 50 ml of cell suspension was directly
injected into the TA muscle of each mouse. All mice used in this
study were humanely sacrificed 28 days after transplantation and
tissue samples were collected.
Quantitative RT-PCR Analysis
Total RNA was isolated using Sepazol reagent (Nacalai Tesque)
according to the manufacturer’s protocol. Residual genomic DNA
was digested and removed with DNase I (Invitrogen). First-strand
cDNA was synthesized using the Superscript III First-Strand
Synthesis System (Invitrogen) for RT-PCR and oligo (dT) 12–18
primers. The cDNA was diluted with DNase-free water at a
concentration of 10 ng/ml. Quantitative RT-PCR was performed
using the PowerSYBR PCR kit (Applied Biosystems) according to
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the manufacturer’s instructions and a StepOne thermal cycler
(Applied Biosystems). We used the Rpl13a and b-actin genes as
invariant controls for mouse and human samples, respectively. For
standardization of mouse iPS cell experiments, cDNA from E13.5
mouse embryo was defined as the control value (1.0). For human
iPS cell experiments, we defined the value of the cDNA from a
teratoma derived from 201B7 (Fig. 6A), or double positive (DP)
(Fig. 6D) as the control value (1.0) for standardization. The
primers are listed i
Histochemical Staining for Osteogenesis and
Chondrogenesis
Alizarin Red and Alcian Blue staining was performed as
previously described [46]. Briefly, cultured cells were fixed with
4% paraformaldehyde in PBS for 5 min at RT and subsequently
washed twice with PBS for 5 min at RT. For calcium detection,
fixed cells were incubated in 1% Alizarin Red S solution (Sigma)
for 5 min at RT and subsequently washed 5 times with PBS at
RT. For the detection of mucopolysaccharide in cartilage, fixed
cells were incubated in 3% acetate solution for 5 min at RT and
subsequently incubated in 1% Alcian Blue 8GX (Sigma) and 3%
acetate solution for 30 min at RT. Finally, the cells were washed 5
times with 3% acetate solution and twice with PBS.
Immunohistochemistry
Immunohistochemical analyses were performed as previously
described [47], and the following antibodies were used: rabbit anti-
DsRed (Clontech; 1:5000), mouse anti-myogenin (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA; 1:400), rabbit anti-dystro-
phin (Abcam; 1:200), mouse anti-Pax7 (R&D; 1:100), rat anti-
laminin a2 (Alexis; 1:150), rabbit anti-b-catenin (Sigma; 1:500),
goat anti-PDGFR-a (R&D; 1:200) and rabbit anti-myosin heavy
chain (R&D; 1:400). A rat MAb satellite cell marker, SM/C-2.6
[33], was kindly provided Dr H. Fukada and used at a dilution of
1:400. Horse radish peroxidase (HRP)-conjugated anti-mouse IgG
(Chemicon), Alexa 488-conjugated anti-rat IgG (Invitrogen), Alexa
488-conjugated anti-mouse IgG (Invitrogen), Alexa 568-conjugat-
ed anti-rabbit IgG (Invitrogen), and Alexa 568-conjugated anti-
goat IgG (Invitrogen) were used as secondary antibodies. For
detection of Pax7, an anti-Pax7 antibody was directly labeled with
Alexa-488 by using the Zenon system (Invitrogen).
Animal Welfare
This study was carried out in strict accordance with the
recommendations in the Regulation on Animal Experimentation
at Kyoto University. The protocols in this study were approved by
the Animal Research Committee of Kyoto University (Protocol
number CiRA1-3 to Hidetoshi Sakurai). All injections were
performed under anesthesia, and all efforts were made to minimize
suffering. Mice were humanely sacrificed prior to tissue collection.
Statistical Analysis
Differences between samples were assessed by using the
Student’s two-tailed t test for independent samples.
Supporting Information
Figure S1 Responses to Activin A of mouse ES/iPS cells
during mesodermal differentiation. (A) Apoptosis of
differentiated mouse ES cells on D1 assessed by a proportion of
Propidium Iodide (PI) positive/AnnexinV positive cell (n = 3). (B)
Nodal expression of differentiated ES and iPS cells on D1. More
Nodal expression was observed in mouse ES cells than mouse iPS
cells. (C) Expression level of early mesendodermal markers in
mouse ES and iPS cells on D3 with (gray bars) or without (black
bars) addition of Activin A (n= 3). Activin A treatment
significantly activated expression of mesoendodermal genes in
both mouse ES and iPS cells. (D) Gene expression profiles of
PDGFR-a+ cells in lower dose treatment of Activin A (n = 3). The
expression levels of Tbx6 and Mesp2 genes were not affected within
those concentration of Activin A. *p,0.05, **p,0.01 between
selected two samples.
(PDF)
Figure S2 Responses to LiCl and Shh of mouse iPS cells
during mesodermal differentiation. (A, B) The expression
of PDGFR-a in mouse iPS cells after differentiation. The gray bars
indicates the percentage of PDGFR-a+ cells in various concentra-
tion of LiCl (A) or Shh (B) (n = 3, each). We choose suitable dose of
LiCl or Shh by the proportion of PDGFR-a+ cells, as 5 mM LiCl
or 10 ng/ml Shh, respectively. (C) LiCl acts as an inducer of Wnt
signaling. The localization of b-catenin shifted from cytoplasmic
region (upper panels) into nucleus (lower panels) after LiCl
treatment. (D) Proliferation of differentiated mouse iPS cells on D6
assessed by BrdU assay (n = 3). Addition of Shh significantly
promoted cell proliferation. (E) Apoptosis of differentiated mouse
ES cells on D6 assessed by a proportion of PI positive/AnnexinV
positive cell (n = 3). Addition of LiCl significantly reduced
apoptosis of differentiated iPS cells. *p,0.05, **p,0.01 between
selected two samples. The bar represents 50 mm.
(PDF)
Figure S3 Morphology of PDGFR-a positive cells after
mesodermal differentiation of mouse iPS cells. PDGFR-
a+ cells (red) are distinguishable by their prominent cellular
clumping on D6 differentiation. The bars represent 100 mm.
(PDF)
Table S1 Primes used for RT-PCR. All forward primers are
indicated in upper rows, and all reverse primers are indicated in
lower rows.
(DOC)
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